Gennadi V. Glinsky - Concepedia

Author

Gennadi V. Glinsky

University of California San Diego ORCID

Also Known As

G Glinsky, G V Glinsky, G. V. GLINSKY, G. V. Glinsky, G.V Glinsky, G.V. Glinsky, Gennadi Glinsky, Gennadi V Glinsky, Gennadi V. Glinsky, Glinsky, G.V.

139

Publications

5.5K

Citations

H-Index

110

Concepts

All Affiliations

University of California San Diego University of Missouri Albany Medical Center Hospital Sidney Kimmel Cancer Center Cancer Research Center

About

Gennadi V. Glinsky is an author at University of California San Diego specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.4K
2	Natural Sciences	10	10	525
3	Engineering	4	4	182
4	Health Sciences	4	4	120
5	Public Health	1	1	19

Gennadi V. Glinsky

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer Gennadi V. Glinsky, Olga Berezovska, Anna B. Glinskii Journal of Clinical Investigation	2005	918
Gene expression profiling predicts clinical outcome of prostate cancer Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Journal of Clinical Investigation	2004	462
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium Vladislav V. Glinsky, Gennadi V. Glinsky, Olga V. Glinskii, Urologic Oncology Seminars and Original Investigations Endothelial Cell PathobiologyAngiogenesisEndothelial DysfunctionPrimary AttachmentCell-matrix Interaction	2004	266
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Vladislav V. Glinsky, Gennadi V. Glinsky, Olga V. Glinskii, PubMed	2003	186
Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells Gennadi V. Glinsky Biomedicines	2020	166
Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate Cancer Olga Berezovska, Anna B. Glinskii, Zhijian Yang, Cell Cycle	2006	156
Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms Gennadi V. Glinsky Cancer Letters Apoptosis Execution MechanismsProfound DeficiencyMedicineApoptosisCell Death	1997	135
Highly specific SNP detection using 2D graphene electronics and DNA strand displacement Michael Taeyoung Hwang, Preston B. Landon, Joon Lee, Proceedings of the National Academy of Sciences	2016	129
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac) Anna B. Glinskii, Gennadi V. Glinsky, Hung‐Yun Lin, Cell Cycle	2009	122
Role of <i>rpoS</i> (katF) in <i>oxyR</i>‐independent regulation of hydroperoxidase I in <i>Escherichia coli</i> Anna Ivanova, Cathy L. Miller, Gennadi V. Glinsky, Molecular Microbiology	1994	104

Page 1